The role of the drug supply in the effective management of diabetes in different health care systems

E. A Mashchenko; V. S Malichenko; S. B Malichenko; A. M Yavisya

doi:10.17816/MSER35810

Medical and Social Expert Evaluation and Rehabilitation ›› 2013, Vol. 16 ›› Issue (4) : 38 -44. DOI: 10.17816/MSER35810

Articles

research-article

The role of the drug supply in the effective management of diabetes in different health care systems

Author information +

History +

PDF

Abstract

Diabetes mellitus (DM) - one of the major problems that threatens health and development of states in the 21st century, and spreads ahead of all non-communicable diseases, assuming the role of a rapidly spreading worldwide epidemic. DM is a socially significant diseases, leading to a decrease in quality of life, early disability and high mortality due to associated complications. At the state level, diabetes is associated with high economic costs not only in public health, but also with total loss associated with loss of productivity and economic growth. The analysis of health care models for patients with diabetes in high income countires, showed high costs and low efficiency (USA), the high cost and high efficiency (France), and low-cost and high efficiency (Japan).

Keywords

diabetes / drug supply / health systems / efficiency

Cite this article

Download citation ▾

E. A Mashchenko, V. S Malichenko, S. B Malichenko, A. M Yavisya. The role of the drug supply in the effective management of diabetes in different health care systems. Medical and Social Expert Evaluation and Rehabilitation, 2013, 16(4): 38-44 DOI:10.17816/MSER35810

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	IDF Diabetes Atlas, 5th ed., 2011

[2]	Sicree R., Shaw J., Zimmet P. The Global Burden. Diabetes and Impaired Glucose Tolerance // IDF Diabetes Atlas fourth // www.idf.org/sites/default/files/The_Global_Burden.pdf

[3]	Глобальное резюме для Всемирного дня здоровья 2012 г. // WHO/DCO/WHD/2012.2 // http://www.who.int/world_health_ day/2012

[4]	Дедов И.И. Сахарный диабет - опаснейший вызов мировому сообществу. Вестник РАМН. 2012; 1: 7-13.

[5]	Older people with type 2 diabetes. European challenges and the need for improved care // Institute of Diabetes for Older People, 2011 // http://instituteofdiabetes.org/wp-content/uploads/2013/03/IDOP-Need-for-Care-050313.pdf

[6]	Кудрин А., Гурвич Е. Старение населения и угроза бюджетного кризиса. Вопросы экономики. 2012; 3: 52-79.

[7]	Старение в XXI веке: триумф и вызов // Фонд Организации Объединенных Наций в области Народонаселения, 2012 // http://www.unfpa.org.ua/files/articles/1/97/UNFPA%20Ageing%20Report%202012%20-%20Exec%20Summary%20 %28RU%29.pdf

[8]	Siraj M.A.T. Global epidemic of diabetes. Nishtar Med. J. 2010; 2(2): 56-60.

[9]	Zhang P. et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res. clin. pract. 2010; 87: 293-301

[10]	Абашидзе А.Х., Маличенко В.С. Обеспечение доступа к лекарственным средствам в условиях развития механизмов защиты прав интеллектуальной собственности. Современное право. 2013; 7: 155.

[11]	Доклад Целевой группы по оценке прогресса в достижении ЦРТ. ООН; 2012.

[12]	The World Bank (2012) The World Bank-data/ Availible: http://data.worldbank.org/.Accessed5Fabruary2012

[13]	Зевелева Г.Н. Государственная политика в области здравоохранения в США в 1992-2012 гг.: борьба за реформы. М.: ИМЭМО РАН, 2012.

[14]	Официальный сайт ОЭСР // http://oecdru.org/oecd_rf.html

[15]	Таннер М. Сравнительный анализ систем здравоохранения в разных странах // http://www.inliberty.ru/library/study/1392

[16]	Кругман П. Охрана здоровья как императив. Экология и жизнь. 2010; 6(103): 85-8. // http://www.ecolife.ru/anna/krugman.pdf

[17]	Kanavos P., van den Aardweg S., Schurer W. Diabetes expenditure, burden of disease and management in 5 EU countries. London: LSE Health, London School of Economics. 2012: 113.